Catalyst Wire Dossier Catalyst Wire Dossier

sIPV + DTaP + HepA (combined vaccination)

· China National Biotec Group Company Limited
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for sIPV + DTaP + HepA (combined vaccination), covering 2020-11-19 to 2020-11-19. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Safety and Immunogenicity of Combined Immunization of sIPV, DTaP and HepA [Phase 4]

See pricing